We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Positive GMP Inspections Raise Hope for Sanofi’s Genzyme Plants
Positive GMP Inspections Raise Hope for Sanofi’s Genzyme Plants
December 6, 2011
Recent positive regulatory inspections of Genzyme’s new Framingham, Mass., facility are lifting hopes that the agency will approve the plant in the first quarter of 2012, and in the meantime allow for additional sales of the company’s Fabry disease drug Fabrazyme, the drugmaker says.